Trinity Biotech (TRIB) Non Operating Income (2010 - 2024)

Trinity Biotech has disclosed Non Operating Income across 14 years of filings, most recently posting $6.5 million for Q4 2024.

• Non Operating Income for Q4 2024 came in at $6.5 million, up 473.87% year-over-year; the trailing twelve-month figure through Dec 2024 was $1.4 million (up 113.98% YoY), and the FY2025 annual result was $202000.0, down 82.76% from the prior year.
• Non Operating Income came in at $6.5 million for Q4 2024 at Trinity Biotech, up from -$2.2 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $6.5 million in Q4 2024 to a low of -$12.0 million in Q1 2022.
• The 5-year median for Non Operating Income is -$1.9 million (2022), against an average of -$2.2 million.
• Across the five-year window, Non Operating Income plunged 7309.88% in 2022 and surged 473.87% in 2024, its largest moves.
• Trinity Biotech's Non Operating Income stood at -$820000.0 in 2020, then sank by 42.32% to -$1.2 million in 2021, then sank by 58.95% to -$1.9 million in 2022, then climbed by 6.95% to -$1.7 million in 2023, then soared by 473.87% to $6.5 million in 2024.
• The last three Non Operating Income figures came in at $6.5 million (Q4 2024), -$2.2 million (Q3 2024), and -$2.8 million (Q2 2024), per Business Quant data.